-
Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate
Tuesday, December 11, 2018 - 1:42pm | 508Clovis Oncology Inc (NASDAQ: CLVS) has emerged as a strong takeover candidate following GlaxoSmithKline plc (NYSE: GSK)'s proposed acquisition of TESARO Inc (NASDAQ: TSRO), according to Gabelli Research. The Analyst Analyst Jing He named Clovis as his top pick in 2019. The analyst...